Oral microbiota promotion for immune system associated inflammations

A method of selectively promoting a desired oral microbiota to treat an inflammation condition caused by an allergic reaction in a subject in need of such treatment comprising:

• providing a preformulated prebiotic edible composition comprising an amino acid containing ingredient comprising L-arginine, the L-arginine configured to be present at a concentration of greater than about 0.1 wt % substantially comprised of separate individual molecules of L-arginine within an oral cavity of the subject;
• substantially removing a biofilm from surfaces comprising the oral cavity, the removing comprising exposing the biofilm to a biofilm degrading enzyme;
• wherein following removal of the biofilm, the composition is contained and at least partially dissolved within an oral cavity of the subject for a period of at least from about 60 seconds to about an 3600 seconds on a daily basis comprising at least one day in an effective amount to selectively promote an increased concentration of selected oral microbiota to thereby treat the inflammation condition, the selectively promoted microbiota comprising Veillonella and Streptococcus at a concentration of about 40 percent to about 70 percent with respect to all bacterial species present from a sampled surface comprising the oral cavity.